View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Market Data
November 20, 2011

Virtify adds Kallik technology to labelling solution

Software developer Virtify has integrated Kallik's Automated Artwork Generation technology to its labelling solution for pharmaceutical and life science companies.

Software developer Virtify has integrated Kallik’s Automated Artwork Generation technology to its labelling solution for pharmaceutical and life science companies.

The new solution enables the creation and management of labelling and product information in several languages.

It also delivers print-ready packaging and labelling artwork, allowing pharmaceutical companies to generate final, consistent and compliant outputs from structured, single-source content.

The Automated Artwork Generation technology allows Virtify to deliver end-to-end solution and compliant labelling from structured content, covering both the pre-submission and post-submission workspaces.

Kallik Limited CEO Neil Gleghorn said by integrating structured content-centric technology, pharma companies can manage patient information from core data sheets through the spectrum of labelling and packaging.

”We estimate that manual transactions can be reduced by 90-95%, potentially saving large pharmaceutical companies tens of millions of pounds," Gleghorn added.

Virtify CEO and founder Satish Tadikonda said the partnership agreement with Kallik allows Virtify to provide complete solutions in the regulatory, supply chain and compliance areas.

”This partnership will allow pharmaceutical companies to evaluate an end-to-end solution for global labelling as opposed to assessing many vendors in siloed organisations," Tadikonda added.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena